Prof. Jacek Jemielity

photo: arch. FNP

Prof. Jacek Jemielity is the head of the Laboratory of Biological Chemistry at the Center for New Technologies UW. He develops methods to synthesize biologically important nucleotides, creates tools to modify nucleic acids useful in studies of genetic information expression and medical applications. He developed a method to obtain mRNA with properties necessary for therapeutic applications. His iventions are used in several clinical trials on cancer immunotherapy. He is the author of over 140 scientific publications in peer-reviewed scientific journals and co-authored 8 patents protecting his inventions. One of these technologies involving mRNA modification is used in clinical trials for cancer vaccines by BioNTech, Sanofi, Roche, Pfizer. He received the 2021 FNP Prize in chemistry. He is a scholarship holder of the Polityka weekly (2008) and and he was nominated in the competition organized by the EPO “European Inventor Award” 2018 in the category “Research”. He is the co-founder and president of ExploRNA Therapeutics, a UW spin off company focused on developing mRNA modification technologies and developing innovative mRNA-based therapies.